• Evolution of Virus inactivation methods in manufacture of biologics

  • De: DD ENTERPRISES
  • Podcast

Evolution of Virus inactivation methods in manufacture of biologics Por arte de portada

Evolution of Virus inactivation methods in manufacture of biologics

De: DD ENTERPRISES
Escúchala gratis

  • Resumen

  • Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses. DNA-based herpesviruses and RNA-based retroviruses are examples of enveloped viruses; DNA-based adenoviruses and RNA-based parvoviruses are examples of nonenveloped viruses.


    Visit Site>> Click Here
    Copyright 2024 DD ENTERPRISES
    Más Menos
activate_primeday_promo_in_buybox_DT
Episodios
  • Evolution of Virus inactivation methods in manufacture of biologics

    Evolution of Virus inactivation methods in manufacture of biologics
    May 29 2024

    Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses.


    Visit Site>> Click Here
    Más Menos
    19 m
Ciencias Sociales
Más Menos

Lo que los oyentes dicen sobre Evolution of Virus inactivation methods in manufacture of biologics

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles